标题
Non‐small cell lung cancer in China
作者
关键词
-
出版物
Cancer Communications
Volume 42, Issue 10, Pages 937-970
出版商
Wiley
发表日期
2022-09-09
DOI
10.1002/cac2.12359
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Asbestos‐related lung cancer: Clinical characteristics and survival outcomes in an Australian cohort seeking workers compensation
- (2022) Rebecca A Hyland et al. Asia-Pacific Journal of Clinical Oncology
- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- First-in-Human Phase I/IB Dose-Finding Study of Adagrasib (MRTX849) in Patients With Advanced KRASG12C Solid Tumors (KRYSTAL-1)
- (2022) Sai-Hong Ignatius Ou et al. JOURNAL OF CLINICAL ONCOLOGY
- Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial
- (2022) Caicun Zhou et al. LANCET ONCOLOGY
- Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial
- (2022) Qing Zhou et al. LANCET ONCOLOGY
- Indoor Air Pollution Increases the Risk of Lung Cancer
- (2022) Ke-Cheng Chen et al. International Journal of Environmental Research and Public Health
- Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in KRAS-mutated non-small cell lung cancer with STK11, KEAP1, or TP53 comutations: subgroup results from the phase III IMpower150 trial
- (2022) Howard Jack West et al. Journal for ImmunoTherapy of Cancer
- 85P Adjuvant osimertinib in patients (pts) with stage IB–IIIA EGFR mutation-positive (EGFRm) NSCLC after complete tumour resection: ADAURA China subgroup analysis
- (2022) W. Jie et al. ANNALS OF ONCOLOGY
- Prediction of lung cancer risk based on age and smoking history
- (2022) Jason H.T. Bates et al. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
- Perioperative comparison of video-assisted thoracic surgery and open lobectomy for pT1-stage non-small cell lung cancer patients in China: a multi-center propensity score-matched analysis
- (2021) Jinming Xu et al. Translational Lung Cancer Research
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prognostic impact of KRAS G12C mutation in patients with NSCLC: results from the ETOP Lungscape Project
- (2021) Stephen P. Finn et al. Journal of Thoracic Oncology
- Osimertinib Versus Comparator EGFR TKI as First-Line Treatment for EGFR-Mutated Advanced NSCLC: FLAURA China, A Randomized Study
- (2021) Ying Cheng et al. Targeted Oncology
- Asthma and asthma symptom control in relation to incidence of lung cancer in the HUNT study
- (2021) Lin Jiang et al. Scientific Reports
- Prognostic Value of Deep Learning-Mediated Treatment Monitoring in Lung Cancer Patients Receiving Immunotherapy
- (2021) Stefano Trebeschi et al. Frontiers in Oncology
- Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art
- (2021) Jin Kang et al. Cancer Communications
- Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020
- (2021) Wei Cao et al. CHINESE MEDICAL JOURNAL
- Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%
- (2021) Martin Reck et al. JOURNAL OF CLINICAL ONCOLOGY
- Cannabis Use, Pulmonary Function, and Lung Cancer Susceptibility: A Mendelian Randomization Study
- (2021) Sebastian-Edgar Baumeister et al. Journal of Thoracic Oncology
- Lung Cancer in Republic of China
- (2021) Yung-Hung Luo et al. Journal of Thoracic Oncology
- PS01.05 Surgical and Clinical Outcomes With Neoadjuvant Atezolizumab in Resectable Stage IB–IIIB NSCLC: LCMC3 Trial Primary Analysis
- (2021) J. Lee et al. Journal of Thoracic Oncology
- Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC
- (2021) Tianqing Chu et al. Journal of Thoracic Oncology
- Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study
- (2021) Yuankai Shi et al. Lancet Respiratory Medicine
- The Prevalence and Concurrent Pathogenic Mutations of KRASG12C in Northeast Chinese Non-small-cell Lung Cancer Patients
- (2021) Yan Liu et al. Cancer Management and Research
- Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-line Treatment for Advanced Squamous Non–Small-Cell Lung Cancer
- (2021) Jie Wang et al. JAMA Oncology
- LBA9 IMpower010: Sites of relapse and subsequent therapy from a phase III study of atezolizumab vs best supportive care after adjuvant chemotherapy in stage IB-IIIA NSCLC
- (2021) E. Felip et al. ANNALS OF ONCOLOGY
- Pairing smoking cessation with lung cancer screening may save lives
- (2021) Mike Fillon CA-A CANCER JOURNAL FOR CLINICIANS
- Amivantamab in EGFR Exon 20 Insertion–Mutated Non–Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study
- (2021) Keunchil Park et al. JOURNAL OF CLINICAL ONCOLOGY
- Taletrectinib (AB-106; DS-6051b) in metastatic non-small cell lung cancer (NSCLC) patients with ROS1 fusion: Preliminary results of TRUST.
- (2021) Caicun Zhou et al. JOURNAL OF CLINICAL ONCOLOGY
- Preliminary safety and efficacy results from phase 1 studies of DZD9008 in NSCLC patients with EGFR Exon20 insertion mutations.
- (2021) James Chih-Hsin Yang et al. JOURNAL OF CLINICAL ONCOLOGY
- Surgical outcomes from the phase 3 CheckMate 816 trial: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo alone as neoadjuvant treatment for patients with resectable non-small cell lung cancer (NSCLC).
- (2021) Jonathan Spicer et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidence of Lung Cancer Among Never-Smoking Asian American, Native Hawaiian, and Pacific Islander Females
- (2021) Mindy C DeRouen et al. JNCI-Journal of the National Cancer Institute
- IMpower150 Final Overall Survival Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC
- (2021) Mark A. Socinski et al. Journal of Thoracic Oncology
- Over-Time Risk of Lung Cancer Is Largely Owing to Continuing Smoking Exposition: A Good Reason to Quit
- (2021) Giuseppe Pelosi et al. Journal of Thoracic Oncology
- Tislelizumab Plus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (RATIONALE 304): A Randomized Phase 3 Trial
- (2021) Shun Lu et al. Journal of Thoracic Oncology
- Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)
- (2021) Caicun Zhou et al. Journal of Thoracic Oncology
- Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
- (2021) Enriqueta Felip et al. LANCET
- Sotorasib for Lung Cancers with KRAS p.G12C Mutation
- (2021) Ferdinandos Skoulidis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung Cancer
- (2021) Bob T. Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetically predicted insomnia and lung cancer risk: a Mendelian randomization study
- (2021) Zhenyu Huo et al. SLEEP MEDICINE
- Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
- (2021) Jianxing He et al. Lancet Respiratory Medicine
- Once-daily savolitinib in Chinese patients with pulmonary sarcomatoid carcinomas and other non-small-cell lung cancers harbouring MET exon 14 skipping alterations: a multicentre, single-arm, open-label, phase 2 study
- (2021) Shun Lu et al. Lancet Respiratory Medicine
- Ensartinib vs Crizotinib for Patients With Anaplastic Lymphoma Kinase−Positive Non–Small Cell Lung Cancer
- (2021) Leora Horn et al. JAMA Oncology
- Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non–Small Cell Lung Cancer
- (2021) Salma K. Jabbour et al. JAMA Oncology
- MA02.01 Efficacy and Safety of Selpercatinib in Chinese Patients With RET Fusion-Positive Non-Small Cell Lung Cancer: A Phase 2 Trial
- (2021) S. Lu et al. Journal of Thoracic Oncology
- Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
- (2021) Shengxiang Ren et al. Journal of Thoracic Oncology
- MA02.02 Efficacy and Safety of Pralsetinib in Chinese Patients with Advanced RET Fusion+ Non-Small Cell Lung Cancer
- (2021) Q. Zhou et al. Journal of Thoracic Oncology
- IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups With EGFR Mutations or Metastases in the Liver or Brain
- (2021) Naoyuki Nogami et al. Journal of Thoracic Oncology
- MA13.08 CHOICE-01: A Phase 3 Study of Toripalimab Versus Placebo in Combination With First-Line Chemotherapy for Advanced NSCLC
- (2021) J. Wang et al. Journal of Thoracic Oncology
- Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer
- (2021) Christian Rolfo et al. Journal of Thoracic Oncology
- Antibody-drug conjugates: A promising novel therapeutic approach in lung cancer
- (2021) Aakash Desai et al. LUNG CANCER
- Leukotriene inhibition and the risk of lung cancer among U.S. veterans with asthma
- (2021) S. Scott Sutton et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Excess Body Weight and Long-Term Incidence of Lung and Colon Cancer in Men; Follow-Up Study of 43 Years
- (2021) Yftach Gepner et al. International Journal of Environmental Research and Public Health
- Treatment Outcomes and Safety of Mobocertinib in Platinum-Pretreated Patients With EGFR Exon 20 Insertion–Positive Metastatic Non–Small Cell Lung Cancer
- (2021) Caicun Zhou et al. JAMA Oncology
- Identification of the Unique Clinical and Genetic Features of Chinese Lung Cancer Patients With EGFR Germline Mutations in a Large-Scale Retrospective Study
- (2021) Xinqing Lin et al. Frontiers in Oncology
- Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first‐line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open‐label, parallel controlled clinical study
- (2021) Jie Zhang et al. Cancer Communications
- Clinical characteristics and outcomes of Chinese patients with KRAS‐mutant non‐small cell lung cancer after chemotherapy
- (2021) Yawen Zheng et al. Cancer Communications
- Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC
- (2021) Yi-Long Wu et al. Journal of Thoracic Oncology
- Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFR T790M+ NSCLC: Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trial
- (2021) Shun Lu et al. Journal of Thoracic Oncology
- Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
- (2020) Shugeng Gao et al. Journal of Thoracic Oncology
- Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration
- (2020) Alexander Drilon et al. NATURE MEDICINE
- Polymorphisms and rare variants identified by next-generation sequencing confer risk for lung cancer in han Chinese population
- (2020) Xiaoqi Li et al. PATHOLOGY RESEARCH AND PRACTICE
- Registrational dataset from the phase I/II ARROW trial of pralsetinib (BLU-667) in patients (pts) with advanced RET fusion+ non-small cell lung cancer (NSCLC).
- (2020) Justin F. Gainor et al. JOURNAL OF CLINICAL ONCOLOGY
- Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations
- (2020) Paul K. Paik et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multi-Level Cross Residual Network for Lung Nodule Classification
- (2020) Juan Lyu et al. SENSORS
- Multiclassifier fusion based on radiomics features for the prediction of benign and malignant primary pulmonary solid nodules
- (2020) Yao Shen et al. Annals of Translational Medicine
- Lung Cancer Occurrence—Correlation with Serum Chromium Levels and Genotypes
- (2020) Piotr Baszuk et al. BIOLOGICAL TRACE ELEMENT RESEARCH
- Giant Circulating Cancer-Associated Macrophage-Like Cells Are Associated With Disease Recurrence and Survival in Non–Small-Cell Lung Cancer Treated With Chemoradiation and Atezolizumab
- (2020) Alexander Augustyn et al. Clinical Lung Cancer
- Pyrotinib in HER2-Mutant Advanced Lung Adenocarcinoma After Platinum-Based Chemotherapy: A Multicenter, Open-Label, Single-Arm, Phase II Study
- (2020) Caicun Zhou et al. JOURNAL OF CLINICAL ONCOLOGY
- Brigatinib Versus Crizotinib in Advanced ALK Inhibitor–Naive ALK-Positive Non–Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial
- (2020) D. Ross Camidge et al. JOURNAL OF CLINICAL ONCOLOGY
- The Invasiveness Classification of Ground-Glass Nodules Using 3D Attention Network and HRCT
- (2020) Yangfan Ni et al. JOURNAL OF DIGITAL IMAGING
- The Regimen of Computed Tomography Screening for Lung Cancer
- (2020) Claudia I. Henschke et al. JOURNAL OF THORACIC IMAGING
- Efficacy and safety of sintilimab plus pemetrexed and platinum as first-line treatment for locally advanced or metastatic nonsquamous non-small cell lung cancer: a randomized, double-blind, phase 3 study (ORIENT-11)
- (2020) Yunpeng Yang et al. Journal of Thoracic Oncology
- The Effect of Advances in Lung-Cancer Treatment on Population Mortality
- (2020) Nadia Howlader et al. NEW ENGLAND JOURNAL OF MEDICINE
- Status of 10 targeted genes of non‐small cell lung cancer in eastern China: A study of 884 patients based on NGS in a single institution
- (2020) Dan Li et al. Thoracic Cancer
- Clinical characteristics and prognostic value of the KRAS G12C mutation in Chinese non-small cell lung cancer patients
- (2020) Si-Yang Liu et al. Biomarker Research
- Outdoor air pollution and cancer: An overview of the current evidence and public health recommendations
- (2020) Michelle C. Turner et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Lung Cancer in People’s Republic of China
- (2020) Shugeng Gao et al. Journal of Thoracic Oncology
- Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC: A Multicenter, Open-label, Phase 1 Trial
- (2020) James Chih-Hsin Yang et al. Journal of Thoracic Oncology
- Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial
- (2020) Mariano Provencio et al. LANCET ONCOLOGY
- Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC
- (2020) Roy S. Herbst et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer
- (2020) Yi-Long Wu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Capmatinib in MET Exon 14–Mutated or MET-Amplified Non–Small-Cell Lung Cancer
- (2020) Jürgen Wolf et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer
- (2020) Alexander Drilon et al. NEW ENGLAND JOURNAL OF MEDICINE
- The mortality of lung cancer attributable to smoking among adults in China and the United States during 1990–2017
- (2020) Xiaoxue Liu et al. Cancer Communications
- Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trial
- (2020) M. Shi et al. ANNALS OF ONCOLOGY
- Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial
- (2020) Wen-Zhao Zhong et al. JOURNAL OF CLINICAL ONCOLOGY
- First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer
- (2020) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
- (2020) Caicun Zhou et al. Lancet Respiratory Medicine
- Expert consensus on neoadjuvant immunotherapy for non-small cell lung cancer
- (2020) Wenhua Liang et al. Translational Lung Cancer Research
- Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater
- (2019) Martin Reck et al. JOURNAL OF CLINICAL ONCOLOGY
- Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial
- (2019) Martin Reck et al. Lancet Respiratory Medicine
- Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-positive Advanced Non-small-cell Lung Cancer in the Global Phase III ALEX Study
- (2019) D. Ross Camidge et al. Journal of Thoracic Oncology
- Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience
- (2019) Badi El Osta et al. Journal of Thoracic Oncology
- Elevated platelet count appears to be causally associated with increased risk of lung cancer: A Mendelian randomization analysis
- (2019) Ying Zhu et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non–Small Cell Lung Cancer Using a Clinicogenomic Database
- (2019) Gaurav Singal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- EGFR and ERBB2 Germline Mutations in Chinese Lung Cancer Patients and Their Roles in Genetic Susceptibility to Cancer
- (2019) Shun Lu et al. Journal of Thoracic Oncology
- K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic Pathways
- (2019) Matthias Scheffler et al. Journal of Thoracic Oncology
- Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
- (2019) Tony S K Mok et al. LANCET
- Erlotinib versus gemcitabine/cisplatin in Chinese patients with EGFR mutation-positive advanced non-small-cell lung cancer: Crossover extension and post-hoc analysis of the ENSURE study
- (2019) Yi-Long Wu et al. LUNG CANCER
- Clinical features and therapeutic options in non‐small cell lung cancer patients with concomitant mutations of EGFR , ALK , ROS1 , KRAS or BRAF
- (2019) Xibin Zhuang et al. Cancer Medicine
- Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study
- (2019) Caicun Zhou et al. Lancet Respiratory Medicine
- Combination of icotinib and chemotherapy as first-line treatment for advanced lung adenocarcinoma in patients with sensitive EGFR mutations: A randomized controlled study
- (2019) Lisheng Xu et al. LUNG CANCER
- Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations
- (2019) Juncheng Dai et al. Lancet Respiratory Medicine
- Exposure to Welding Fumes, Hexavalent Chromium, or Nickel and Lung Cancer Risk
- (2019) Beate Pesch et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Pleural Plaques and the Risk of Lung Cancer in Asbestos-exposed Subjects
- (2019) Fraser JH Brims et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Ten-Year Trends of Clinicopathologic Features and Surgical Treatment of Lung Cancer in China
- (2019) Ruochuan Zang et al. ANNALS OF THORACIC SURGERY
- Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
- (2019) Alessandro Leonetti et al. BRITISH JOURNAL OF CANCER
- Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer
- (2019) Vanita Noronha et al. JOURNAL OF CLINICAL ONCOLOGY
- Real-world prevalence of programmed death ligand 1 expression in locally advanced or metastatic non–small-cell lung cancer: The global, multicenter EXPRESS study
- (2019) M. Dietel et al. LUNG CANCER
- The prevalence of programmed death ligand-1 (PD-L1) expression in non-small cell lung cancer in an unselected, consecutive population
- (2019) Birgit Guldhammer Skov et al. MODERN PATHOLOGY
- Validation of the diagnostic efficiency of folate receptor-positive circulating tumor cells in lung cancers: a prospective observational study
- (2019) Jingbo Liu et al. Translational Cancer Research
- Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non–Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study
- (2019) Yukio Hosomi et al. JOURNAL OF CLINICAL ONCOLOGY
- Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
- (2019) Suresh S. Ramalingam et al. NEW ENGLAND JOURNAL OF MEDICINE
- A manifold learning regularization approach to enhance 3D CT image-based lung nodule classification
- (2019) Ying Ren et al. International Journal of Computer Assisted Radiology and Surgery
- Short-term association between ambient air pollution and lung cancer mortality
- (2019) Ning Wang et al. ENVIRONMENTAL RESEARCH
- Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial
- (2019) Yunpeng Yang et al. Lancet Respiratory Medicine
- Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study
- (2018) S Novello et al. ANNALS OF ONCOLOGY
- Outcomes of Pemetrexed-based chemotherapies in HER2-mutant lung cancers
- (2018) Yan Wang et al. BMC CANCER
- Exposure–response analysis of alectinib in crizotinib-resistant ALK-positive non-small cell lung cancer
- (2018) Peter N. Morcos et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Adoption Rate of Video-Assisted Thoracic Surgery for Lung Cancer Varies Widely in China
- (2018) Jianqiao Cai et al. CHEST
- Efficacy and Safety of Necitumumab Continuation Therapy in the Phase III SQUIRE Study of Patients With Stage IV Squamous Non–Small-Cell Lung Cancer
- (2018) Tudor Ciuleanu et al. Clinical Lung Cancer
- Molecular profiling of lung cancer specimens and liquid biopsies using MALDI-TOF mass spectrometry
- (2018) Eleonora Bonaparte et al. Diagnostic Pathology
- Targeting EGFR in Lung Cancer: Current Standards and Developments
- (2018) Asunción Díaz-Serrano et al. DRUGS
- Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial
- (2018) Bob T. Li et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non–Small-Cell Lung Cancer
- (2018) Yi-Long Wu et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project
- (2018) Ming Sound Tsao et al. Journal of Thoracic Oncology
- Comparison of genetic profiles among primary lung tumor, metastatic lymph nodes and circulating tumor DNA in treatment-naïve advanced non-squamous non-small cell lung cancer patients
- (2018) Fangfang Xie et al. LUNG CANCER
- Community-based lung cancer screening with low-dose CT in China: Results of the baseline screening
- (2018) Wenjia Yang et al. LUNG CANCER
- Radiomics analysis of pulmonary nodules in low-dose CT for early detection of lung cancer
- (2018) Wookjin Choi et al. MEDICAL PHYSICS
- Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer
- (2018) Jacqulyne P. Robichaux et al. NATURE MEDICINE
- Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
- (2018) Mark A. Socinski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
- (2018) Jean-Charles Soria et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chronic Obstructive Pulmonary Disease in Lung Cancer Patients: Prevalence, Underdiagnosis, and Clinical Characterization
- (2018) Cecilia Mouronte-Roibás et al. RESPIRATION
- The link between chronic obstructive pulmonary disease phenotypes and histological subtypes of lung cancer: a case–control study
- (2018) Wei Wang et al. International Journal of Chronic Obstructive Pulmonary Disease
- Liquid biopsy for lung cancer early detection
- (2018) Mariacarmela Santarpia et al. Journal of Thoracic Disease
- Alectinib versus crizotinib in treatment-naïve anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study
- (2018) S Gadgeel et al. ANNALS OF ONCOLOGY
- Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non–Small Cell Lung Cancer
- (2018) Yi-Long Wu et al. Journal of Thoracic Oncology
- Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
- (2018) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Real-world EGFR testing in patients with stage IIIB/IV non-small-cell lung cancer in North China: A multicenter, non-interventional study
- (2018) Ying Cheng et al. Thoracic Cancer
- Estimation of Overdiagnosis of Lung Cancer in Low-Dose Computed Tomography Screening
- (2018) Bruno Heleno et al. JAMA Internal Medicine
- Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial
- (2018) Dongsheng Yue et al. Lancet Respiratory Medicine
- Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non–Small Cell Lung Cancer
- (2018) Baohui Han et al. JAMA Oncology
- Is high vitamin B12 status a cause of lung cancer?
- (2018) Anouar Fanidi et al. INTERNATIONAL JOURNAL OF CANCER
- SELECT: A Phase II Trial of Adjuvant Erlotinib in Patients With Resected Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer
- (2018) Nathan A. Pennell et al. JOURNAL OF CLINICAL ONCOLOGY
- The changing diagnostic pathway for lung cancer patients in Shanghai, China
- (2017) Tao Jiang et al. EUROPEAN JOURNAL OF CANCER
- Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial
- (2017) Baohui Han et al. INTERNATIONAL JOURNAL OF CANCER
- Osimertinib in Pretreated T790M-Positive Advanced Non–Small-Cell Lung Cancer: AURA Study Phase II Extension Component
- (2017) James Chih-Hsin Yang et al. JOURNAL OF CLINICAL ONCOLOGY
- Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non–Small-Cell Lung Cancer Harboring ROS1 Rearrangement
- (2017) Sun Min Lim et al. JOURNAL OF CLINICAL ONCOLOGY
- EGFR Mutation Subtypes Influence Survival Outcomes following First-Line Gefitinib Therapy in Advanced Asian NSCLC Patients
- (2017) Natalia Sutiman et al. Journal of Thoracic Oncology
- PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project
- (2017) Fred R. Hirsch et al. Journal of Thoracic Oncology
- First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study
- (2017) Jean-Charles Soria et al. LANCET
- Dabrafenib plus trametinib in patients with previously untreated BRAF V600E -mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial
- (2017) David Planchard et al. LANCET ONCOLOGY
- Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial
- (2017) Alice T Shaw et al. LANCET ONCOLOGY
- EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE study
- (2017) Baohui Han et al. LUNG CANCER
- Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes
- (2017) James D McKay et al. NATURE GENETICS
- Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
- (2017) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
- (2017) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Advent of Ultra-high Volume Thoracic Surgical Centers in Shanghai
- (2017) Alan D. L. Sihoe et al. WORLD JOURNAL OF SURGERY
- Using Deep Learning for Classification of Lung Nodules on Computed Tomography Images
- (2017) QingZeng Song et al. Journal of Healthcare Engineering
- Clinical Significance of Folate Receptor-positive Circulating Tumor Cells Detected by Ligand-targeted Polymerase Chain Reaction in Lung Cancer
- (2017) Lin Wang et al. Journal of Cancer
- Unique distribution of programmed death ligand 1 (PD-L1) expression in East Asian non-small cell lung cancer
- (2017) Yunjian Pan et al. Journal of Thoracic Disease
- Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases
- (2017) et al. JAMA Oncology
- Lung Cancer Screening With Low-Dose Computed Tomography in the United States—2010 to 2015
- (2017) Ahmedin Jemal et al. JAMA Oncology
- The Management of Patients With Stage IIIA Non–Small Cell Lung Cancer With N2 Mediastinal Node Involvement
- (2017) Renato G. Martins et al. Journal of the National Comprehensive Cancer Network
- Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma
- (2017) Yuping Li et al. PLoS One
- Single nucleotide polymorphisms in DNA repair genes and putative cancer risk
- (2016) Beate Köberle et al. ARCHIVES OF TOXICOLOGY
- BRAF mutations in non-small cell lung cancer: has finally Janus opened the door?
- (2016) Rafael Caparica et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Radiation exposure and lung disease in todayʼs nuclear world
- (2016) Steven D. Deas et al. CURRENT OPINION IN PULMONARY MEDICINE
- Particulate matter air pollution components and risk for lung cancer
- (2016) O. Raaschou-Nielsen et al. ENVIRONMENT INTERNATIONAL
- Estimation of heritability for nine common cancers using data from genome-wide association studies in Chinese population
- (2016) Juncheng Dai et al. INTERNATIONAL JOURNAL OF CANCER
- MassARRAY, pyrosequencing, and PNA clamping for EGFR mutation detection in lung cancer tissue and cytological samples: a multicenter study
- (2016) Kyueng-Whan Min et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Randomized Phase II Trial of Gefitinib With and Without Pemetrexed as First-Line Therapy in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations
- (2016) Ying Cheng et al. JOURNAL OF CLINICAL ONCOLOGY
- PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2016) Suresh Senan et al. JOURNAL OF CLINICAL ONCOLOGY
- Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study)
- (2016) Michael Kreuter et al. Journal of Thoracic Oncology
- New and emerging targeted treatments in advanced non-small-cell lung cancer
- (2016) Fred R Hirsch et al. LANCET
- Clinical characteristics and outcome of patients with lung cancer harboring BRAF mutations
- (2016) Claire Tissot et al. LUNG CANCER
- EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center
- (2016) Riccardo Giannini et al. ONCOLOGY REPORTS
- Ceritinib: a Review in ALK-Positive Advanced NSCLC
- (2016) Emma D. Deeks Targeted Oncology
- The short-term association between asthma hospitalisations, ambient temperature, other meteorological factors and air pollutants in Hong Kong: a time-series study
- (2016) Holly Ching-yu Lam et al. THORAX
- Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses
- (2016) Nikhil K. Khankari et al. PLOS MEDICINE
- Fruits, vegetables and lung cancer risk: a systematic review and meta-analysis
- (2015) A. R. Vieira et al. ANNALS OF ONCOLOGY
- Lifestyle and Cancer Risk
- (2015) Verena A Katzke et al. CANCER JOURNAL
- Prevalence and clinicopathological characteristics of ALK fusion subtypes in lung adenocarcinomas from Chinese populations
- (2015) Difan Zheng et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non–Small-Cell Lung Cancer: KCSG-LU05-04
- (2015) Jin Seok Ahn et al. JOURNAL OF CLINICAL ONCOLOGY
- BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Caicun Zhou et al. JOURNAL OF CLINICAL ONCOLOGY
- The 2015 World Health Organization Classification of Lung Tumors
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- Folate Receptor–Positive Circulating Tumor Cell Detected by LT-PCR–Based Method as a Diagnostic Biomarker for Non–Small-Cell Lung Cancer
- (2015) Xiaoxia Chen et al. Journal of Thoracic Oncology
- Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study
- (2015) Luis Paz-Ares et al. LANCET ONCOLOGY
- Comprehensive investigation of oncogenic driver mutations in Chinese non-small cell lung cancer patients
- (2015) Rui Wang et al. Oncotarget
- Home kitchen ventilation, cooking fuels, and lung cancer risk in a prospective cohort of never smoking women in Shanghai, China
- (2014) Christopher Kim et al. INTERNATIONAL JOURNAL OF CANCER
- Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
- (2014) Mark G. Kris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Smoking Prevalence and Cigarette Consumption in 187 Countries, 1980-2012
- (2014) Marie Ng et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Liquid Biopsies: Genotyping Circulating Tumor DNA
- (2014) Luis A. Diaz et al. JOURNAL OF CLINICAL ONCOLOGY
- Subclassification of pulmonary non-small cell lung carcinoma in fine needle aspirates using a limited immunohistochemistry panel
- (2014) Kusum Kapila et al. Journal of Cytology
- Stressful social relations and mortality: a prospective cohort study
- (2014) Rikke Lund et al. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
- Projected Outcomes Using Different Nodule Sizes to Define a Positive CT Lung Cancer Screening Examination
- (2014) David S. Gierada et al. JNCI-Journal of the National Cancer Institute
- Hereditary Lung Cancer Syndrome Targets Never Smokers with Germline EGFR Gene T790M Mutations
- (2014) Adi Gazdar et al. Journal of Thoracic Oncology
- A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)
- (2014) Yuankai Shi et al. Journal of Thoracic Oncology
- Cisplatin versus Carboplatin-Based Regimens for the Treatment of Patients with Metastatic Lung Cancer. An Analysis of Veterans Health Administration Data
- (2014) Rafael Santana-Davila et al. Journal of Thoracic Oncology
- Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data
- (2014) LANCET
- Epidemiology: The dominant malignancy
- (2014) Eric Bender NATURE
- Acquired resistance to TKIs in solid tumours: learning from lung cancer
- (2014) D. Ross Camidge et al. Nature Reviews Clinical Oncology
- First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
- (2014) Benjamin J. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
- (2014) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Folate Receptor-Positive Circulating Tumor Cells as a Novel Diagnostic Biomarker in Non-Small Cell Lung Cancer
- (2014) Yue Yu et al. Translational Oncology
- Histological subtypes of lung cancer in Chinese women from 2000 to 2012
- (2014) Xiao Nong Zou et al. Thoracic Cancer
- Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer
- (2014) Edward F. Patz et al. JAMA Internal Medicine
- KIF5B-RETfusions in Chinese patients with non-small cell lung cancer
- (2013) Weijing Cai et al. CANCER
- The use of stained cytologic direct smears forALKgene rearrangement analysis of lung adenocarcinoma
- (2013) Bryan L. Betz et al. CANCER CYTOPATHOLOGY
- Is video-assisted thoracic surgery lobectomy better than thoracotomy for early-stage non-small-cell lung cancer? A systematic review and meta-analysis
- (2013) Zhenrong Zhang et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Kurtosis and skewness assessments of solid lung nodule density histograms: differentiating malignant from benign nodules on CT
- (2013) Ayano Kamiya et al. JAPANESE JOURNAL OF RADIOLOGY
- Preselection Based on Clinical Characteristics in German Non–Small-Cell Lung Cancer Patients Screened for EML4-ALK Translocation
- (2013) Amanda Laura Helen Tufman et al. Journal of Thoracic Oncology
- A phase I/II trial of Tumor Treating Fields (TTFields) therapy in combination with pemetrexed for advanced non-small cell lung cancer
- (2013) Miklos Pless et al. LUNG CANCER
- K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
- (2013) Jonathan M. Ostrem et al. NATURE
- Time to ESCAPE the city? Air pollution linked to lung cancer
- (2013) Bryony Jones Nature Reviews Clinical Oncology
- Quantification of Rare Circulating Tumor Cells in Non-Small Cell Lung Cancer by Ligand-Targeted PCR
- (2013) Jiatao Lou et al. PLoS One
- Subclassification of Non-Small Cell Lung Cancer by Cytologic Sampling: A Logical Approach with Selective Use of Immunocytochemistry
- (2012) Hillary Z. Kimbrell et al. ACTA CYTOLOGICA
- Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study
- (2012) M. Kreuter et al. ANNALS OF ONCOLOGY
- Weeklynab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
- (2012) Mark A. Socinski et al. JOURNAL OF CLINICAL ONCOLOGY
- A Novel Mass Spectrometry–Based Assay for Diagnosis of EML4-ALK–Positive Non–Small Cell Lung Cancer
- (2012) Kazuko Sakai et al. Journal of Thoracic Oncology
- Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys
- (2012) Gary A Giovino et al. LANCET
- Radiomics: the process and the challenges
- (2012) Virendra Kumar et al. MAGNETIC RESONANCE IMAGING
- Association analyses identify multiple new lung cancer susceptibility loci and their interactions with smoking in the Chinese population
- (2012) Jing Dong et al. NATURE GENETICS
- Association between Chronic Obstructive Pulmonary Disease and Lung Cancer: A Case-Control Study in Southern Chinese and a Meta-Analysis
- (2012) Hui Wang et al. PLoS One
- Effect of the Interaction Between Outdoor Air Pollution and Extreme Temperature on Daily Mortality in Shanghai, China
- (2011) Yuexin Cheng et al. JOURNAL OF EPIDEMIOLOGY
- Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410
- (2011) W. J. Curran et al. JNCI-Journal of the National Cancer Institute
- New driver mutations in non-small-cell lung cancer
- (2011) William Pao et al. LANCET ONCOLOGY
- A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese
- (2011) Zhibin Hu et al. NATURE GENETICS
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Global Patterns of Cancer Incidence and Mortality Rates and Trends
- (2010) A. Jemal et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Surgery With or Without Preoperative Paclitaxel and Carboplatin in Early-Stage Non–Small-Cell Lung Cancer: Southwest Oncology Group Trial S9900, an Intergroup, Randomized, Phase III Trial
- (2010) Katherine M.W. Pisters et al. JOURNAL OF CLINICAL ONCOLOGY
- Preoperative Chemotherapy Plus Surgery Versus Surgery Plus Adjuvant Chemotherapy Versus Surgery Alone in Early-Stage Non–Small-Cell Lung Cancer
- (2010) Enriqueta Felip et al. JOURNAL OF CLINICAL ONCOLOGY
- Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
- (2010) Anne Aupérin et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer Risks After Radiation Exposure in Middle Age
- (2010) I. Shuryak et al. JNCI-Journal of the National Cancer Institute
- Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: A propensity-matched analysis from the STS database
- (2010) Subroto Paul et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression
- (2010) Xuchao Zhang et al. Molecular Cancer
- Clinicopathologic Features of Non-Small-Cell Lung Cancer with EML4–ALK Fusion Gene
- (2009) Tsuyoshi Takahashi et al. ANNALS OF SURGICAL ONCOLOGY
- Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL
- (2009) Martin Reck et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK
- (2009) Alice T. Shaw et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non–Small-Cell Lung Cancer: Updated Survival Analysis of JBR-10
- (2009) Charles A. Butts et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Results of the International Adjuvant Lung Cancer Trial Evaluating Adjuvant Cisplatin-Based Chemotherapy in Resected Lung Cancer
- (2009) Rodrigo Arriagada et al. JOURNAL OF CLINICAL ONCOLOGY
- Lymph Node Dissection for Lung Cancer: Significance, Strategy, and Technique
- (2009) Shun-ichi Watanabe et al. Journal of Thoracic Oncology
- Plasma DNA Quantification in Lung Cancer Computed Tomography Screening
- (2008) Gabriella Sozzi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer
- (2008) J. P. Koivunen et al. CLINICAL CANCER RESEARCH
- Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
- (2008) Jean-Pierre Pignon et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups
- (2008) Gary M. Strauss et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
- (2008) Giorgio Vittorio Scagliotti et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search